Program Partner: MilliporeSigma
Audiovisual Sponsor: Piramal Pharma Solutions
Beverage Break Sponsor: Bristol-Myers Squibb
Pharmaceutical companies, CDMOs/CMOs and suppliers are contending with an evolving pharmaceutical manufacturing value chain marked by increased product complexity, greater technological demands, and elongated supply chains while confronting the ever-present need to assure supply and quality. This program will share insight from leading executives on how their companies are addressing these challenges in both the near and long term.
Category/Sourcing Manager of the Future What will be required of the sourcing/category manager of the future? How will the manufacturing, technological, and supply-chain requirements of today shape the functions, capabilities, and skill sets needed for tomorrow? Leading pharmaceutical companies share their vision of the future and the key elements of their talent acquisition and capability development programs.
Cecilia Luz Cariaga, Director, Sourcing Excellence, R&D, Bristol-Myers Squibb
Supplier Relationship Management: Case Study in Supplier Innovation Leveraging the benefits of supplier-enabled innovation is an important way for pharmaceutical companies to realize value for their operations, improve their bottom line, and potentially gain competitive advantage. How can supplier innovation be best cultivated with specific ideas for implementation? Drawing on models used by GE, Roche and Disney, learn about Johnson & Johnson’s new Center for Excellence for Supplier Innovation and hear first hand how the company is partnering with its suppliers to bring innovation to fruition.
Maura Hobson, Manager, Global Procurement, Janssen Pharmaceuticals
Darcy Birse, PhD, Global Executive Director, GE Healthcare Life Sciences
Materials Management for Complex Supply Chains: Antibody Drug Conjugates As product complexity increases, so do the requirements for sourcing and supply chain management. Learn best practices for managing internal and external manufacturing networks for antibody drug conjugates from a leading pharmaceutical company.
Firelli Alonso, PhD, Senior Director, External Supply, BioTherapeutics Pharmaceutical Sciences, Pfizer Biotech
Value-Based Metrics: Panel Discussion How can pharmaceutical companies and suppliers move beyond traditional metrics to measure the gains from value-creation activities? Gain insight into innovative metrics being used to measure supplier performance and the metrics of “customer of choice” used by suppliers to evaluate procurement organizations.
Keith Robinson, Associate Director, Global Supplier Performance and Development, Bristol-Myers Squibb
Marilyn Jacobs, Director, Global Business Excellence, Janssen Supply Group, LLC., a Johnson & Johnson Company
Tim Hanson, Director, External Supply, Amgen
Attendees should pre-register and pre-pay for DCAT Week programs and events before March 15, 2017 (5pm ET). Confirmations and receipts will be emailed to registrants when payment is received.
Member Badges: On or about Thursday, March 16, 2017, DCAT members will receive an email with an e-ticket attachment confirming all of their pre-registrations for DCAT Week. Attendees should print the e-ticket (or store it on their phone) and bring it with them to DCAT Week. The QR code on the ticket can be used to quickly print a member badge or to scan attendees into all of the programs and events they have pre-registered for throughout the week. A separate badge system will be used for non-member registrants.
Badge Pickup Locations during DCAT Week:
Walk-ins are welcome if space permits. All walk-ins must pay with a credit card or check. Walk-ins cannot be invoiced.
Speaker bios have been requested from presenters and will be posted here as they are received.
Dr. Firelli Alonso is Senior Director, External Supply, BioTherapeutics Pharmaceutical Sciences at Pfizer, Inc. She heads the BioTherapeutics and Vaccines Outsourcing group in Worldwide Research and Development. Dr. Alonso has more than 33 years of combined experience in research, development, and cGMP production of biological products and vaccines, and more than 11 years of experience in outsourcing, project/contract management, and technology transfer to qualified third parties. Her areas of expertise include viral vectors and vaccine development, biotherapeutics and vaccine process development and cGMP production, project management, technology transfer, outsourcing, and budgets and operations. Prior to joining Wyeth/Pfizer in 1996, Dr. Alonso was at The Salk Institute (Government Services Division), a vaccine contract manufacturer for the U.S. Army. She obtained her Ph.D. in Microbiology from the University of Alabama in Birmingham, followed by postdoctoral research at the U.S. Army Medical Research Institute for Infectious Diseases, Sloan-Kettering Institute for Cancer Research, and Rutgers University Center for Advanced Biotechnology and Medicine.
Darcy Birse is Global Executive Director, Global Strategic Accounts at GE Healthcare Life Sciences, where he is responsible for global strategic partnerships within the GE Commercial organization. He joined GE in 2007 and has held various global positions at GE Healthcare and has more than 25 years of experience in the life sciences sector. Prior to his current role at GE, Darcy held global positions at GE Healthcare, directing FastTrak BioPharma Services with operations in the US, Europe, Asia and emerging growth markets. Darcy has held key roles in the biopharmaceutical industry, including directing R&D scientists in developing biotechnology drug/biologic products; Vice President of Biopharmaceutical Development at TGN Biotech; directing cGMP biopharmaceutical testing and working with regulatory authorities at the contract research organization, MDS Pharma Services; and Director of Process Development at Dendreon, where he completed a successful regulatory biologics license application filing to the US Food and Drug Administration for the autologous cell therapy product, Provenge, the first cell-based cancer vaccine to be approved and marketed. He also is a longstanding member of the Advisory Board for the BioProcessing Journal.
Darcy’s academic background includes: Assistant Professor in Biochemistry and Biophysics at Stockholm University, Sweden; an EMBO post-doctoral fellow in Biochemistry; a PhD in physics from Joseph Fourier University/EMBL in Grenoble, France; a D.E.A. degree in Structural Biology in Strasbourg, France; and a B.Sc. in Chemistry from Dalhousie University, Canada.
Cecilia Luz Cariaga leads capability development for Bristol Myers Squibb’s Sourcing Excellence organization, the talent and leadership development pipeline for Global Procurement. She also serves as the head of Sourcing Excellence for Research and Development. Her over 20-year career began in new product development with Procter & Gamble and was strengthened through leadership experience at A.T. Kearney where she served consumer, pharmaceutical, chemical, and banking clients worldwide. Ms. Cariaga has delivered new product launches for mature and emerging markets, driven merger and acquisition integrations, transformed organizations and established new ones. She is an influential sourcing strategist who delivers financial benefits and value beyond savings through patient/consumer/customer-centric strategies, designed with supply chain and commercial partners. She has an earned reputation of expertise in end-to-end global markets for direct materials, and other categories requiring an innovative mindset. Ms. Cariaga holds a Bachelor of Science degree in Chemical Engineering from the University of Pennsylvania and a Masters in Management from the Kellogg School of Northwestern University.
Maura Hobson is Manager, Global Procurement at Janssen Pharmaceuticals where she is responsible for the supplier management and category management responsibilities for biologics and vaccines materials. This includes holding the position of a Global Supplier Relationship manager, ensuring business continuity through risk management, development of supplier enabled innovation, and value improvement across the supply chain. Prior to this role, Maura held various positions within technical operations and R&D functions, both at Janssen and Merck & Co., Inc. with responsibilities for biologics and vaccines commercial product support and new product launch and technical transfer activities. She obtained a bachelor’s of science in biology from Bucknell University, a master’s degree in microbiology and immunology from Boston University, and a master business administration from Villanova University.
Tim Hanson is the Director within Amgen’s External Supply organization based in Thousand Oaks, California, where he is responsible for the implementation and oversight of Amgen’s Supplier Relationship Excellence program, building partnerships with key suppliers via strategic pillars (Technical, Quality, Supply Chain and Robust Relationship) to ensure patient supply. Previous to this role, Tim had responsibilities at Amgen managing product distribution, managing the contract manufacturing supply chain, and implementing Amgen’s planning system for finished goods. Prior to Amgen, Tim worked in numerous supply Chain roles within the electronics and multimedia industries, including several years in Europe.
Marilyn Jacobs is Director, Global Business Excellence at Janssen Supply Group, LLC., a Johnson & Johnson Company. In her current position, Marilyn provides business support to parenteral manufacturing in order to drive reliability and enable continuous improvement. Marilyn has held various positions supporting operations, procurement, quality, planning and information technology in applying the various methods of process improvement. She is a Johnson & Johnson Certified Master Black Belt, Certified Project Manager, and Certified Kepner Tregoe Facilitator.
InterContinental Barclay (Grand Ballroom)
111 East 48th Street
New York, New York 10017
Map & Directions
To cancel your program registration and receive a refund, you must call the DCAT office by March 15, 2017 (5pm ET) at +1-800-640-3228.
Refunds with receptions may be subject to a processing fee due to hotel guarantees.
The DCAT organization regrets that no refunds can be given after March 15, 2017 (5pm ET).
Registration payments made by credit card will be refunded within two to three business days from the date of cancellation.
Registration payments made by check will be refunded within 20 days of the program date.
Education program topics for DCAT Week are selected and developed by members of DCAT's Education Committee and other volunteer task forces of the organization. Speakers are selected based on their expertise and/or experience related to these topics, their ability to impart important information and concepts, and their willingness to do so without promoting specific business interests. By advance meetings with speakers, reviewing materials and slide presentations, DCAT volunteers make every effort to ensure that each program is a relevant, value-added experience for our members.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.